The fear of a trade war over pharmaceuticals between the EU and the US has been avoided for now, but the European Commission ...
NEW YORK, NY, USA I April 01, 2025 I Pfizer Inc. (NYSE: PFE) announced today that the European Commission (EC) has issued a decision amending the marketing ...
Zacks.com on MSN6d
PFE Secures EU Nod for Expanded Use of RSV Vaccine AbrysvoThe latest decision makes Pfizer's Abrysvo the first RSV vaccine approved for use in non-pregnant adults under 50 years of ...
Pfizer’s RSV vaccine Abrysvo receives European approval to help protect adults aged 18-59 against RSV lower respiratory tract disease: New York Wednesday, April 2, 2025, 09:00 H ...
Zacks Investment Research on MSN6h
AbbVie's Rinvoq Gets EU Nod for 8th Indication Giant Cell ArteritisAbbVie ABBV announced that the European Commission has granted marketing approval to its blockbuster drug Rinvoq for treating ...
No other country in the EU fears Donald Trump’s tariffs and the consequences of his global trade war more than Ireland.
Ryanair on Wednesday lost its fight against 650 million euros ($702 million) of Polish state aid granted to Polish airline ...
Genmab has announced that the European Commission (EC) has approved Tivdak (tisotumab vedotin) to treat recurrent or ...
NICE recommended Pfizer's Adcetris for NHS use in advanced Hodgkin lymphoma, citing strong trial data and a new discount agreement with Takeda.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback